The South African government says it could fill the potential gap in the number of doses it will need of the twice-yearly HIV-prevention jab to end Aids by 2043, by getting a group of local pharmaceutical companies to make generic shots from 2027 onwards. There is, however, a hitch. None of the companies that will be involved have a licence from lenacapavir’s inventor, Gilead Sciences, to make the jab.
Related Posts
Naturals Beauty Celebrates 18 Years With Two New Skincare Launches
Cape Town – What started in a South African mother’s kitchen 18 years ago has grown into homegrown skincare brand Naturals Beauty, which is […]
ANC, SACP Not Amused By DA Shower Billboard
Johannesburg – The African National Congress (ANC) and its Tripartite partner, the South African Communist Party (SACP), are not amused with the cheeky shower […]
Match report: St Stithians dominates Clifton College
Louis McAlsin scores a try for St Stithians. Photo: Mthulisi Lwazi Khuboni The St Stithians Sports Festival is in full swing, and the rugby […]